Jane Street
NAGE

Jane Street’s Niagen Bioscience NAGE Stock Holding History

Jane Street’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-357,238
Closed -$1.93M – 13425
2025
Q4 		$2.27M Buy
357,238
+199,206
+126% +$1.39M ﹤0.01% 4568
2025
Q3 		$1.47M Buy
158,032
+83,291
+111% +$841K ﹤0.01% 5500
2025
Q2 		$1.08M Sell
74,741
-12,801
-15% -$126K ﹤0.01% 5474
2025
Q1 		$604K Buy
87,542
+64,351
+277% +$404K ﹤0.01% 6515
2024
Q4 		$123K Sell
23,191
-22,521
-49% -$123K ﹤0.01% 8670
2024
Q3 		$167K Buy
45,712
+22,889
+100% +$72K ﹤0.01% 8760
2024
Q2 		$62.3K Sell
22,823
-205,412
-90% -$687K ﹤0.01% 8873
2024
Q1 		$794K Buy
228,235
+184,484
+422% +$341K ﹤0.01% 5818
2023
Q4 		$62.6K Buy
+43,751
New +$61K ﹤0.01% 8726
2023
Q2 		– Sell
-19,144
Closed -$29.3K – 9740
2023
Q1 		$29.3K Buy
19,144
+6,546
+52% +$11.7K ﹤0.01% 8578
2022
Q4 		$21.2K Buy
+12,598
New +$20K ﹤0.01% 8600
2022
Q3 		– Sell
-10,848
Closed -$18K – 10647
2022
Q2 		$18K Buy
+10,848
New +$21.2K ﹤0.01% 9192
2021
Q4 		– Sell
-32,264
Closed -$203K – 10938
2021
Q3 		$203K Buy
+32,264
New +$266K ﹤0.01% 8815
2021
Q2 		– Sell
-76,651
Closed -$668K – 10548
2021
Q1 		$716K Buy
+76,651
New +$608K ﹤0.01% 6127
2018
Q4 		– Sell
-21,058
Closed -$90K – 5874
2018
Q3 		$90K Buy
+21,058
New +$90.5K ﹤0.01% 4863

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jane Street's NAGE Position: Q1 2026 in Review

Jane Street sold out of Niagen Bioscience (NAGE) in Q1 2026, closing a stake of 357,238 shares — an estimated $1.93M sold.

Jane Street first reported a position in NAGE in Q3 2018 and held it in 15 quarters. The position peaked at $2.27M in Q4 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Jane Street reported no remaining Niagen Bioscience position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 357,238 Niagen Bioscience shares in Q1 2026, an estimated $1.93M.
  • Jane Street first reported a position in Niagen Bioscience in Q3 2018 and held it in 15 quarters.
  • Jane Street's Niagen Bioscience position peaked at $2.27M in Q4 2025.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.